Reaction
Bladder Cancer Recurrent reporting signals
As of the last recalculation, Bladder Cancer Recurrent appears in 985 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is PIOGLITAZONE (PRR 84.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Pioglitazone | 147 | 84.3 | 84.5 |
| Gemcitabine | 33 | 18.3 | 18.3 |
| Gemcitabine Hydrochloride | 36 | 14.8 | 14.9 |
| Sitagliptin | 40 | 12.2 | 12.2 |
| Glipizide | 30 | 10.7 | 10.7 |